Literature DB >> 2935570

Vasopressin in circulatory control and hypertension.

C I Johnston.   

Abstract

Recently, there has been an explosion of knowledge on vasopressin, including its neuro-anatomy, biochemistry and physiology. Recent work demonstrates extensive extra-hypothalamic vasopressinergic projections from the SON and PVN. Of particular importance are projections to the cardiovascular medullary centres. Conversely, the SON and PVN receive reciprocal catecholaminergic innervation from autonomic medullary centres. Vasopressin should now be regarded as a peptide hormone with important peripheral effects, as well as a neuropeptide acting as a neurotransmitter or neuromodulator with important CNS actions. The central and peripheral vasopressin systems are not only anatomically differentiated, but, although integrated, may also function independently. There is an important interaction between the central vasopressin system and the autonomic nervous system. Vasopressin has multiple and diverse actions on the cardiovascular system, including direct vasoconstriction, antidiuresis and hence volume control, central actions on cardiovascular neural centres, modulation of the baroreflex and direct cardiac effects. It also acts in concert with the sympathetic nervous system and the renin-angiotensin system as an integrated neurohormonal system in the control of blood pressure. Vasopressin appears to have an important role as a vasoconstrictor agent whenever volume is threatened, such as in dehydration, haemorrhage, adrenal insufficiency and orthostasis. It seems unlikely that vasopressin acts as a direct vasoconstrictor agent in the pathogenesis of any form of experimental or human hypertension. Although plasma vasopressin levels have been reported to be elevated in most forms of hypertension, this correlates best with the severity of hypertension. Furthermore, the levels are not elevated to the pressor range, so that increased vascular reactivity and sensitivity has to invoked. This does not appear to be specific for vasopressin. However, vasopressin may be indirectly involved through volume maintenance or interactions within the CNS. Indeed, its volume retaining properties have probably been underestimated. Whereas in acute situations the vasoconstrictor properties may be of some importance, it is difficult to sustain long-term hypertension without maintenance of an adequate plasma volume. Vasopressin's central actions on the cardiovascular medullary centres, the baroreflex, the autonomic nervous system and catecholamine metabolism may also be involved in some hypertensive processes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935570     DOI: 10.1097/00004872-198512000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  21 in total

Review 1.  The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.

Authors:  Yoko Fujiwara; Akito Tanoue; Gozoh Tsujimoto; Taka-Aki Koshimizu
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

2.  V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity.

Authors:  Taka-aki Koshimizu; Yoshihisa Nasa; Akito Tanoue; Ryo Oikawa; Yuji Kawahara; Yasushi Kiyono; Tetsuya Adachi; Toshiki Tanaka; Tomoyuki Kuwaki; Toyoki Mori; Satoshi Takeo; Hitoshi Okamura; Gozoh Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

3.  An increased extrasynaptic NMDA tone inhibits A-type K+ current and increases excitability of hypothalamic neurosecretory neurons in hypertensive rats.

Authors:  Meng Zhang; Vinicia C Biancardi; Javier E Stern
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

4.  Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes.

Authors:  Y Xu; R L Hopfner; J R McNeill; V Gopalakrishnan
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 5.  Cardiovascular effects of melanocortins.

Authors:  Michael H Humphreys; Xi-Ping Ni; David Pearce
Journal:  Eur J Pharmacol       Date:  2011-01-01       Impact factor: 4.432

6.  Regulation of Neuronal Activity in Hypothalamic Vasopressin Neurons.

Authors:  Toyoaki Ohbuchi; Juhee Haam; Jeffrey G Tasker
Journal:  Interdiscip Inf Sci       Date:  2015

7.  The influence of vasopressin on the arterioles and venules of skeletal muscle of the rat during systemic hypoxia.

Authors:  J M Marshall; J Lloyd; R Mian
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

8.  The role of vasopressin in the regional vascular responses evoked in the spontaneously breathing rat by systemic hypoxia.

Authors:  A M Louwerse; J M Marshall
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

9.  Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.

Authors:  L Arnolda; B P McGrath; M Cocks; C I Johnston
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  Gene regulation system of vasopressin and corticotropin-releasing hormone.

Authors:  Masanori Yoshida
Journal:  Gene Regul Syst Bio       Date:  2008-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.